Lincoln Pharmaceuticals informs about issuance of duplicate share certificate

12 May 2023 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company has received the enclosed intimation letter from its RTA –Link Intime India, regarding the duplicate share certificate of the Company that have been issued, the details of which are enclosed. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate share certificates.

The above information is a part of company’s filings submitted to BSE.


Lincoln Pharma Share Price

620.60 -0.40 (-0.06%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.